RENEE SCARAMUZZINO: Open Payments
NPI 1346812401 · UTICA, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,421 in 114 payments from 17 companies in 2025. Trend: 2023 $3,091 · 2024 $3,272 · 2025 $2,421
Food & beverage: $2,232Education: $189
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 23 | $481 |
| GlaxoSmithKline, LLC. | 26 | $476 |
| Actelion Pharmaceuticals US, Inc. | 7 | $265 |
| GENZYME CORPORATION | 10 | $205 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 9 | $172 |
| Regeneron Healthcare Solutions, Inc. | 9 | $169 |
| Verona Pharma, Inc. | 6 | $135 |
| Electromed, Inc. | 5 | $112 |
| Viatris Specialty LLC | 5 | $111 |
| Insmed, Inc. | 5 | $91 |
Products named: DUPIXENT, FASENRA, NUCALA, OPSUMIT, TRELEGY ELLIPTA, AIRSUPRA, Ohtuvayre, OFEV.
Industry payments across NY — which companies pay providers there.
